983 related articles for article (PubMed ID: 31270110)
1. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Hellmich B; Agueda A; Monti S; Buttgereit F; de Boysson H; Brouwer E; Cassie R; Cid MC; Dasgupta B; Dejaco C; Hatemi G; Hollinger N; Mahr A; Mollan SP; Mukhtyar C; Ponte C; Salvarani C; Sivakumar R; Tian X; Tomasson G; Turesson C; Schmidt W; Villiger PM; Watts R; Young C; Luqmani RA
Ann Rheum Dis; 2020 Jan; 79(1):19-30. PubMed ID: 31270110
[TBL] [Abstract][Full Text] [Related]
2. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
Monti S; Águeda AF; Luqmani RA; Buttgereit F; Cid M; Dejaco C; Mahr A; Ponte C; Salvarani C; Schmidt W; Hellmich B
RMD Open; 2019; 5(2):e001003. PubMed ID: 31673411
[TBL] [Abstract][Full Text] [Related]
3. The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis.
Ughi N; Padoan R; Crotti C; Sciascia S; Carrara G; Zanetti A; Rozza D; Monti S; Camellino D; Muratore F; Emmi G; Quartuccio L; Morbelli S; El Aoufy K; Tonolo S; Caporali R; De Vita S; Salvarani C; Cimmino MA
Reumatismo; 2022 Feb; 73(4):. PubMed ID: 35130681
[TBL] [Abstract][Full Text] [Related]
4. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
Dejaco C; Ramiro S; Duftner C; Besson FL; Bley TA; Blockmans D; Brouwer E; Cimmino MA; Clark E; Dasgupta B; Diamantopoulos AP; Direskeneli H; Iagnocco A; Klink T; Neill L; Ponte C; Salvarani C; Slart RHJA; Whitlock M; Schmidt WA
Ann Rheum Dis; 2018 May; 77(5):636-643. PubMed ID: 29358285
[TBL] [Abstract][Full Text] [Related]
5. EULAR recommendations for the management of large vessel vasculitis.
Mukhtyar C; Guillevin L; Cid MC; Dasgupta B; de Groot K; Gross W; Hauser T; Hellmich B; Jayne D; Kallenberg CG; Merkel PA; Raspe H; Salvarani C; Scott DG; Stegeman C; Watts R; Westman K; Witter J; Yazici H; Luqmani R;
Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
[TBL] [Abstract][Full Text] [Related]
6. Comparing treatment options for large vessel vasculitis.
Macaluso F; Marvisi C; Castrignanò P; Pipitone N; Salvarani C
Expert Rev Clin Immunol; 2022 Aug; 18(8):793-805. PubMed ID: 35714219
[TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary.
Bardi M; Diamantopoulos AP
Radiol Med; 2019 Oct; 124(10):965-972. PubMed ID: 31254221
[TBL] [Abstract][Full Text] [Related]
8. [Large-vessel vasculitis-giant cell and Takayasu arteritis].
Villiger PM
Internist (Berl); 2019 Oct; 60(10):1059-1073. PubMed ID: 31471629
[TBL] [Abstract][Full Text] [Related]
9. Reducing the Toxicity of Long-Term Glucocorticoid Treatment in Large Vessel Vasculitis.
Palmowski A; Buttgereit F
Curr Rheumatol Rep; 2020 Oct; 22(12):85. PubMed ID: 33047263
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
Hellmich B; Águeda AF; Monti S; Luqmani R
Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
[TBL] [Abstract][Full Text] [Related]
11. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
Narváez J; Estrada P; LLop D; Vidal-Montal P; Brugarolas E; Maymó-Paituvi P; Palacios-Olid J; Nolla JM
Semin Arthritis Rheum; 2023 Apr; 59():152166. PubMed ID: 36645992
[TBL] [Abstract][Full Text] [Related]
13. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
Banerjee S; Quinn KA; Gribbons KB; Rosenblum JS; Civelek AC; Novakovich E; Merkel PA; Ahlman MA; Grayson PC
J Rheumatol; 2020 Jan; 47(1):99-107. PubMed ID: 30877209
[TBL] [Abstract][Full Text] [Related]
14. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
Maz M; Chung SA; Abril A; Langford CA; Gorelik M; Guyatt G; Archer AM; Conn DL; Full KA; Grayson PC; Ibarra MF; Imundo LF; Kim S; Merkel PA; Rhee RL; Seo P; Stone JH; Sule S; Sundel RP; Vitobaldi OI; Warner A; Byram K; Dua AB; Husainat N; James KE; Kalot MA; Lin YC; Springer JM; Turgunbaev M; Villa-Forte A; Turner AS; Mustafa RA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1071-1087. PubMed ID: 34235871
[TBL] [Abstract][Full Text] [Related]
15. Biologic treatment of large-vessel vasculitides.
Schäfer VS; Zwerina J
Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica.
Spies CM; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S172-7. PubMed ID: 21044455
[TBL] [Abstract][Full Text] [Related]
17. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update.
Dejaco C; Ramiro S; Bond M; Bosch P; Ponte C; Mackie SL; Bley TA; Blockmans D; Brolin S; Bolek EC; Cassie R; Cid MC; Molina-Collada J; Dasgupta B; Nielsen BD; De Miguel E; Direskeneli H; Duftner C; Hočevar A; Molto A; Schäfer VS; Seitz L; Slart RHJA; Schmidt WA
Ann Rheum Dis; 2024 May; 83(6):741-751. PubMed ID: 37550004
[TBL] [Abstract][Full Text] [Related]
18. Management of large-vessel vasculitis.
Salvarani C; Hatemi G
Curr Opin Rheumatol; 2019 Jan; 31(1):25-31. PubMed ID: 30461542
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab monotherapy for large vessel vasculitis: results of 104-week treatment of a prospective, single-centre, open study.
Saito S; Okuyama A; Okada Y; Shibata A; Sakai R; Kurasawa T; Kondo T; Takei H; Amano K
Rheumatology (Oxford); 2020 Jul; 59(7):1617-1621. PubMed ID: 31665468
[TBL] [Abstract][Full Text] [Related]
20. A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis.
Misra DP; Sharma A; Kadhiravan T; Negi VS
Autoimmun Rev; 2017 Feb; 16(2):179-191. PubMed ID: 27988436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
